Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in KRRO — Korro Bio, Inc.

CIK 886982 NEW YORK, NY
Back to KRRO Full portfolio

Position in KRRO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,541,835
+$969,711 QoQ
Shares Held
116,983
+131.5% QoQ
Ownership
0.794%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KRRO Over Time

Shares Held

Position Value (USD)

Derivatives in KRRO

reported options exposure · as of Mar 31, 2021
CallValue
$0
CallShares
33,200
PutValue
$0
PutShares
18,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,246,746 across 360 Biotechnology names. KRRO ranks #238 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in KRRO

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,541,835 116,983
2026-03-31 $572,124 50,541
2025-12-31 $416,119 51,950
2025-09-30 $750,962 15,681
2025-03-31 $364,635 20,944
2024-12-31 $887,069 23,301
2024-09-30 $428,243 12,814
2024-06-30 $304,525 8,991
2024-03-31 $4,065,390 45,171